Junping Shi
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 16
- PARP inhibition in cancer therapy 4
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 3
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Haitao Zhao (4 shared papers)Honglin Guo (4 shared papers)Xiaobo Yang (3 shared papers)Xiaoliang Shi (4 shared papers)Kai Wang (8 shared papers)Jianzhen Lin (3 shared papers)Junfeng Liu (1 shared paper)Xinting Sang (3 shared papers)
- Journals
- The Oncologist (5 papers)Journal of Clinical Oncology (4 papers)Annals of Translational Medicine (2 papers)Clinical Cancer Research (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junping Shi
24 papers receiving 337 citations
Peers
Comparison fields: 5 of 43
- Oncology 184
- Cancer Research 86
- Hepatology 40
- Pulmonary and Respiratory Medicine 134
- Pathology and Forensic Medicine 60
Countries citing papers authored by Junping Shi
This map shows the geographic impact of Junping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Shi more than expected).
Fields of papers citing papers by Junping Shi
This network shows the impact of papers produced by Junping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Shi. The network helps show where Junping Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Junping Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 80 | |
| 2 | 2020 | 36 | |
| 3 | 2020 | 28 | |
| 4 | 2021 | 27 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 17 | |
| 9 | 2019 | 15 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 11 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 4 | |
| 16 | 2020 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2020 | 2 | |
| 20 | 2018 | 1 |
About Junping Shi
Junping Shi is a scholar working on Oncology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 24 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Lung Cancer Treatments and Mutations (8 papers), Genetic factors in colorectal cancer (5 papers), PARP inhibition in cancer therapy (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (184 citations), Cancer Research (86 citations), Hepatology (40 citations), Pulmonary and Respiratory Medicine (134 citations) and Pathology and Forensic Medicine (60 citations). Junping Shi has collaborated with scholars based in China and United States. Frequent co-authors include Haitao Zhao, Honglin Guo, Xiaobo Yang, Xiaoliang Shi, Kai Wang, Jianzhen Lin, Junfeng Liu, Xinting Sang, Wenting Chen and Ke Hu. Their work appears in journals such as The Oncologist, Journal of Clinical Oncology, Annals of Translational Medicine, Clinical Cancer Research and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.